Compare Charles River Laboratories Intl. Inc (CRL) vs Commvault Systems Inc (CVLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Commvault Systems Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while Commvault Systems Inc trades at $157.25 (market cap $6.25B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 2.3× Commvault Systems Inc's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Commvault Systems Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Commvault Systems Inc for 17 Days on average.
| CRL | CVLT | |
|---|---|---|
Market Cap | $14.23B | $6.25B |
Volume | 1,176,885 | 632,727 |
Sector | Health | Technology |
52-Week High | $310.77 | $176.52 |
52-Week Low | $149.93 | $75.18 |
Typical Hold Time | 33 Days | 17 Days |
Enterprise Value | $17.06B | $6.24B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $301.79, up 0.5% with strong analyst support (73% buy ratings) and a $305.50 consensus target. The stock shows bullish technical momentum above key support levels, though fundamentals reveal challenges with negative net income margins (-5.96%) and elevated P/E ratio (684.85). Recent quarterly earnings beats and a new 2030 growth strategy provide optimism, but profitability concerns persist amid flat revenue trends.
The outlook balances near-term technical strength against fundamental headwinds. Investment opportunity lies in execution of the 5-7% growth target and $300M savings plan, while risks include sustained negative profitability, high debt levels ($2.24B), and margin pressure. Current price near resistance at $304 suggests limited upside without fundamental improvement.
CVLT trades at $157.25, up 4.64% today, with a bullish technical signal and strong institutional interest. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Recent news highlights include achieving AWS Data Competency and expanding FedRAMP High authorization, reinforcing its cyber resilience leadership.
The outlook is positive, supported by analyst consensus and recent strategic wins, though high valuation multiples and a projected decline in net profit margin for 2026 present risks. Upside potential exists if earnings momentum continues, but investors should weigh premium valuations against growth sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Commvault Systems Inc
Commvault provides enterprise-grade data protection and information management software. Its platform helps businesses manage, back up, and recover data across on-premises, cloud, and hybrid environments.
Read more on CVLT →
